About QSAM Biosciences
QSAM Biosciences is a company based in Palm Beach (United States) founded in 2004 was acquired by Telix Pharma in February 2024.. The company has 4 employees as of December 31, 2021. QSAM Biosciences operates in a competitive market with competitors including SpringWorks Therapeutics, Sana Biotechnology, Janux Therapeutics, GigaGen and Kronos Bio, among others.
- Headquarter Palm Beach, United States
- Employees 4 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Q2earth Inc.
-
Annual Revenue
-
Net Profit
$-4.39 M20as on Dec 31, 2023
-
EBITDA
$-3.94 M28as on Dec 31, 2023
-
Latest Funding Round
$2.5 M (USD), Post-IPO
Jan 28, 2021
-
Investors
Telix Pharmaceuticals
& 1 more
-
Employee Count
4
as on Dec 31, 2021
-
Acquired by
Telix Pharma
(Feb 08, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of QSAM Biosciences
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $2.5M
-
First Round
First Round
(31 Mar 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Post-IPO - QSAM Biosciences | Valuation |
investors |
|
| Apr, 2017 | Amount | Post-IPO - QSAM Biosciences | Valuation |
investors |
|
| Mar, 2017 | Amount | Post-IPO - QSAM Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in QSAM Biosciences
QSAM Biosciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Telix Pharmaceuticals and Checkmate Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Checkmate Capital is backed by family office for private equity.
|
Founded Year | Domain | Location | |
|
Theranostic radiopharmaceuticals are developed for cancer imaging and therapy.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by QSAM Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QSAM Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qsam Biosciences Comparisons
Competitors of QSAM Biosciences
QSAM Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpringWorks Therapeutics, Sana Biotechnology, Janux Therapeutics, GigaGen and Kronos Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for cancer and rare diseases.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Chimeric antigen receptor macrophages are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Qsam Biosciences
Frequently Asked Questions about QSAM Biosciences
When was QSAM Biosciences founded?
QSAM Biosciences was founded in 2004 and raised its 1st funding round 13 years after it was founded.
Where is QSAM Biosciences located?
QSAM Biosciences is headquartered in Palm Beach, United States. It is registered at Palm Beach, Florida, United States.
Who is the current CEO of QSAM Biosciences?
Kevin Bolin is the current CEO of QSAM Biosciences.
How many employees does QSAM Biosciences have?
As of Dec 31, 2021, the latest employee count at QSAM Biosciences is 4.
What does QSAM Biosciences do?
Nuclear medicines for treating bone cancer and bone marrow ablation are developed by QSAM Biosciences, founded in 2004 and based in Palm Beach, United States. Operations focus on radiopharmaceuticals like Samarium-153 DOTMP, known as CycloSam, which emits beta and gamma radiation to target cancer cells. Applications include osteosarcoma, metastatic bone cancers, immune and blood diseases, and sickle cell conditions within the biotechnology sector.
Who are the top competitors of QSAM Biosciences?
QSAM Biosciences's top competitors include SpringWorks Therapeutics, Janux Therapeutics and Kronos Bio.
Who are QSAM Biosciences's investors?
QSAM Biosciences has 2 investors. Key investors include Telix Pharmaceuticals, and Checkmate Capital.